Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ANIK > SEC Filings for ANIK > Form 8-K on 21-Jun-2013All Recent SEC Filings

Show all filings for ANIKA THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ANIKA THERAPEUTICS INC


21-Jun-2013

Submission of Matters to a Vote of Security Holders, Financial Statements


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its Annual Meeting of Stockholders on June 18, 2013. Proxies were solicited pursuant to the Company's proxy statement filed on April 23, 2013, with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934. There was no solicitation in opposition to the Company's solicitation. At the meeting, holders of the Company's common stock were asked:

1. To elect two (2) Class II directors nominated by the Board of Directors, each to serve until the 2016 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2. To consider and approve an amendment to the Anika Therapeutics, Inc. Second Amended and Restated 2003 Stock Option and Incentive Plan; To ratify the appointment of PricewaterhouseCoopers LLP as the Company's
3. independent registered public accounting firm for the 2013 fiscal year; and
4. To consider and approve an advisory vote regarding the compensation of the Company's Named Executive Officers.

A total of 12,665,197 shares of Common Stock were present in person or by proxy at the meeting, representing approximately 90% of the voting power of the Company entitled to vote. Each share of the Company's common stock was entitled to one vote with respect to matters submitted to a vote of the Company's stockholders, and the voting results reported below are final.

PROPOSAL 1

Each of the Company's nominees for director as listed in the proxy statement was
re-elected as shown in the table below:

                                                           Broker
               Nominee         Votes "For" Votes Withheld Non-Votes
               Raymond J. Land  9,228,217     687,321     2,749,659

               John C. Moran    9,213,597     701,941     2,749,659

PROPOSAL 2

Stockholders also approved an amendment to the Anika Therapeutics, Inc. Second Amended and Restated 2003 Stock Option and Incentive Plan as shown in the table below:

Broker
For Against Abstained Non-Votes
8,882,301 1,014,369 18,868 2,749,659


PROPOSAL 3

Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2013 fiscal year as shown in the table below:

Broker For Against Abstained Non-Votes 12,368,118 284,929 12,150 0

PROPOSAL 4

Stockholders approved, on an advisory basis, the compensation paid to the Company's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion set forth in the Proxy Statement of the Meeting as shown in the table below:

Broker For Against Abstained Non-Votes 8,554,193 1,298,733 62,612 2,749,659



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

10.1 Amendment to Anika Therapeutics, Inc. Second Amended and Restated 2003 Stock Option and Incentive Plan


  Add ANIK to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ANIK - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.